FALZARANO, Maria Sofia
 Distribuzione geografica
Continente #
NA - Nord America 7.471
AS - Asia 3.912
EU - Europa 3.128
SA - Sud America 692
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 94
OC - Oceania 61
Totale 15.502
Nazione #
US - Stati Uniti d'America 7.227
SG - Singapore 1.469
CN - Cina 943
PL - Polonia 768
IT - Italia 707
BR - Brasile 555
VN - Vietnam 430
DE - Germania 428
HK - Hong Kong 306
UA - Ucraina 268
GB - Regno Unito 259
TR - Turchia 201
CA - Canada 129
FI - Finlandia 127
FR - Francia 127
JP - Giappone 109
BD - Bangladesh 108
RU - Federazione Russa 104
IN - India 103
SE - Svezia 100
MX - Messico 81
ID - Indonesia 62
AR - Argentina 55
NL - Olanda 52
AU - Australia 46
BE - Belgio 40
ZA - Sudafrica 40
ES - Italia 38
PK - Pakistan 31
IQ - Iraq 30
CO - Colombia 23
CZ - Repubblica Ceca 19
LT - Lituania 17
MA - Marocco 17
CL - Cile 15
VE - Venezuela 15
PH - Filippine 14
NZ - Nuova Zelanda 13
MY - Malesia 11
RO - Romania 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EC - Ecuador 10
SA - Arabia Saudita 10
AT - Austria 9
IE - Irlanda 9
TH - Thailandia 9
PT - Portogallo 8
EG - Egitto 7
KE - Kenya 7
BO - Bolivia 6
CR - Costa Rica 6
JO - Giordania 6
KR - Corea 6
NP - Nepal 6
PE - Perù 6
IL - Israele 5
JM - Giamaica 5
TN - Tunisia 5
AZ - Azerbaigian 4
EE - Estonia 4
KZ - Kazakistan 4
LB - Libano 4
QA - Qatar 4
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
Totale 15.338
Città #
Ashburn 902
Singapore 899
Warsaw 764
Fairfield 605
Woodbridge 517
San Jose 451
Houston 363
Ann Arbor 360
Chandler 355
Beijing 347
Santa Clara 315
Hong Kong 291
Jacksonville 289
Seattle 233
Wilmington 219
Cambridge 180
Los Angeles 162
New York 160
Dallas 147
Ho Chi Minh City 120
Munich 106
Hanoi 103
Izmir 98
Milan 92
Nanjing 91
Tokyo 91
Ferrara 85
Council Bluffs 80
Princeton 74
Boardman 65
Lauterbourg 62
Shanghai 60
São Paulo 59
Orem 53
Rome 53
San Diego 53
Mexico City 48
Brescia 46
Dong Ket 44
Toronto 44
Bremen 43
Helsinki 40
London 40
Montreal 40
Brussels 39
Jakarta 39
Buffalo 38
Brooklyn 33
Johannesburg 33
Addison 31
Turku 31
Chicago 30
Phoenix 30
Chennai 29
Denver 29
Hefei 29
Stockholm 29
Tianjin 29
The Dalles 28
Sydney 25
Atlanta 24
Frankfurt am Main 24
Poplar 23
Shenyang 22
Nanchang 21
Boston 20
Changsha 20
Bologna 19
Da Nang 19
Jinan 19
Moscow 18
Hebei 17
Naples 17
Brno 15
Dearborn 15
Jiaxing 15
Haiphong 14
Charlotte 13
Mumbai 13
Nuremberg 13
Auburn Hills 12
Florence 12
Manchester 12
Norwalk 12
Perth 12
Rio de Janeiro 12
San Francisco 12
Amsterdam 11
Brasília 11
Falls Church 11
Miami 11
Querétaro 11
Wan Chai 11
Zhengzhou 11
Ankara 10
Baghdad 10
Biên Hòa 10
Curitiba 10
Hamilton 10
Redwood City 10
Totale 10.333
Nome #
Duchenne muscular dystrophy: From diagnosis to therapy 574
Meccanismi del danno neuronale indotto dalla tossina mitocondriale sodio azide in colture primarie di corteccia di ratto. Effetti sulle Protein Kinasi C. 503
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 478
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 412
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 374
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 321
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 320
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 284
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 277
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 276
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 273
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 265
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 262
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 253
Exon skipping-mediated dystrophin reading frame restoration for small mutations 245
Spatial RNA-mapping reveals the unique patterns of expression and localisation of dystrophin isoforms in the human adult normal brain to improve understanding of brain involvement in muscular dystrophy 242
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 238
Sodium Azide Induced Neuronal Damage In Vitro: Evidence for Non-Apoptotic Cell Death 237
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 227
Sodium azide: a useful tool for in vitro studying neurodegenerative diseases. 225
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 223
Biodistribution Studies of Polymeric Nanoparticles for Drug Delivery in Mice. 218
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 214
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 211
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 210
Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices 207
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 199
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 194
Physical and transcriptional characterization of human urinary stem cell populations 189
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 189
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 188
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 186
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 186
MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping 182
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 182
Protective effect of a peptide derived from the endogenous PKC inhibitor PKI55 on the neurosecretory function in ischemic brain slices 181
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 181
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 179
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 178
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 177
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 176
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for duchenne muscular dystrophy. 174
null 172
Oligomeric formylpeptide activity on human neutrophils 172
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 170
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 170
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 168
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 168
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 168
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 167
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 164
Protein kinase C isoforms changes induced by chemical ischemia-reperfusion in rat cerebral cortex slices 163
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 162
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 161
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 158
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 158
Nanodiagnostics and nanodelivery applications in genetic alterations 153
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 151
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 145
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 143
Nanoparticles to deliver antisense oligonucleotides aimed at exon skipping therapies 141
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 121
Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. 120
Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases 120
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 115
null 113
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 112
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 112
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 111
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 110
Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. 102
null 96
new pyrazolyl ureas as potent human neutrophil chemotaxis inhibitors 96
null 94
null 92
null 92
null 90
null 87
null 80
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils 75
Totale 15.502
Categoria #
all - tutte 62.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 772
Totale 62.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022840 31 101 58 27 28 26 62 45 33 53 124 252
2022/2023853 79 80 25 112 165 110 48 58 80 15 53 28
2023/2024582 44 45 40 16 27 104 31 52 22 18 13 170
2024/20252.198 47 36 161 115 263 227 130 108 350 258 264 239
2025/20265.905 624 267 496 829 970 370 649 270 427 571 318 114
2026/2027180 180 0 0 0 0 0 0 0 0 0 0 0
Totale 15.502